BAC
Bank of America Corporation
BAC has a slight edge over SKWD overall, supported by stronger modeled upside and stronger fundamentals.
SKWD
Skyward Specialty Insurance Group, Inc.
SKWD's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SKWD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
SKWD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like SKWD.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SKWD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $62.67 | — |
| Cheap | 13x | $56.39 | -10% |
| Fair | 15x | $63.66 | +1.6% |
| Current | 15x | $62.67 | — |
| Expensive | 18x | $78.45 | +25% |
Historical ranges are pointers, not guarantees.
SKWD has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over SKWD on the outlook, with more favorable profitability expectations.
SKWD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for SKWD, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
SKWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.32 | +24% |
| Q3 2026 | $4.28 | +27% |
| Q2 2026 | $4.29 | +36% |
| Q1 2026 | $4.15 | +39% |
| Q4 2025 | $4.07 | +42% |
| Q3 2025 | $3.37 | +2.7% |
| Q2 2025 | $3.16 | +6.8% |
| Q1 2025 | $2.98 | +9.6% |
| Q4 2024 | $2.87 | +28% |
SKWD has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over SKWD on profitability, with a higher operating margin.
SKWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $455.3M | +19% |
| Q2 2026 | $489.5M | +53% |
| Q1 2026 | $475.9M | +45% |
| Q4 2025 | $385.6M | +27% |
| Q3 2025 | $382.5M | +27% |
| Q2 2025 | $319.9M | +14% |
| Q1 2025 | $328.5M | +24% |
| Q4 2024 | $304.4M | +24% |
SKWD has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -1.8 points |
| Q2 2026 | 13% | -2.6 points |
| Q1 2026 | 13% | -2.6 points |
| Q4 2025 | 14% | +8.1 points |
| Q3 2025 | 16% | +0.3 points |
| Q2 2025 | 16% | +1.2 points |
| Q1 2025 | 16% | -2.1 points |
| Q4 2024 | 6.1% | -9.2 points |
SKWD's operating margin was 14% last quarter, down 1.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with SKWD at up 76%.
SKWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $50.1M | +140% |
| Q3 2025 | $168.9M | +0.8% |
| Q2 2025 | $87.1M | +372% |
| Q1 2025 | $96.6M | +2.7% |
| Q3 2024 | $167.6M | +52% |
| Q2 2024 | $18.4M | +2589% |
| Q1 2024 | $94M | -12% |
| Q3 2023 | $110.1M | +82% |
SKWD's free cash flow was $403M over the past year, up 34% from the year before. Free cash flow isn't a meaningful measure for financial services companies like SKWD.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SKWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SKWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +107K shares |
| 1 year | +9.4% | +3.9M shares |
| 3 years | +19% | +7.4M shares |
| 5 years | +26% | +9.5M shares |
| Available history | +22% | +8.2M shares |
SKWD has 46M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $125,000 |
| Q2 2026 | $10.8M |
| Q1 2026 | $8.7M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SKWD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 1.4x | Healthy |
| Q3 2022 | 3.0x | Elevated |
| Q2 2022 | 0.7x | Very low |
| Q1 2022 | 0.6x | Very low |
| Q4 2021 | 1.6x | Healthy |
| Q3 2021 | 0.7x | Very low |
SKWD's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SKWD.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SKWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.2 | Neutral |
| Stochastic | 64.5 | Neutral |
SKWD's weekly RSI is 63 (neutral) and its Stochastic is 64 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SKWD on valuation relative to its sector.
SKWD PE vs Financial Services Sector
| Metric | SKWD | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 12% above |
| PE % | 43 | 53 | 10 pts below |
SKWD is trading at 15x earnings, a 12% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SKWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.0 | 6.3% above |
| 20 week MA | $59.1 | 6.1% above |
| 50 week MA | $51.8 | 21% above |
| 100 week MA | $51.4 | 22% above |
| 200 week MA | $41.7 | 50% above |
SKWD has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SKWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $19.1 | $33.9 | +77% |
| 2024 | $33.9 | $50.8 | +50% |
| 2025 | $50.8 | $51.9 | +2.1% |
| 2026 YTD | $51.9 | $62.7 | +21% |
SKWD has the edge over BAC on returns for 2026, with the stronger performance.